192 related articles for article (PubMed ID: 23074978)
1. A case-control study of chronic myelomonocytic leukemia (CMML) in Shanghai, China: evaluation of risk factors for CMML, with special focus on benzene.
Gross SA; Irons RD; Scott PK; Galbraith D; Wang XQ; Chen Y; Paustenbach D
Arch Environ Occup Health; 2012; 67(4):206-18. PubMed ID: 23074978
[TBL] [Abstract][Full Text] [Related]
2. Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure.
Irons RD; Gross SA; Le A; Wang XQ; Chen Y; Ryder J; Schnatter AR
Chem Biol Interact; 2010 Mar; 184(1-2):30-8. PubMed ID: 19941839
[TBL] [Abstract][Full Text] [Related]
3. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification.
Wong O; Harris F; Armstrong TW; Hua F
Chem Biol Interact; 2010 Mar; 184(1-2):112-28. PubMed ID: 19900423
[TBL] [Abstract][Full Text] [Related]
4. A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification.
Wong O; Harris F; Armstrong TW; Hua F
Chem Biol Interact; 2010 Mar; 184(1-2):129-46. PubMed ID: 19900422
[TBL] [Abstract][Full Text] [Related]
5. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
[TBL] [Abstract][Full Text] [Related]
6. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification.
Wong O; Harris F; Yiying W; Hua F
Regul Toxicol Pharmacol; 2009 Dec; 55(3):340-52. PubMed ID: 19703505
[TBL] [Abstract][Full Text] [Related]
7. Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
Emanuel PD
Leukemia; 2008 Jul; 22(7):1335-42. PubMed ID: 18548091
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia.
Ngo NT; Lampert IA; Naresh KN
Br J Haematol; 2008 Jun; 141(6):771-81. PubMed ID: 18371110
[TBL] [Abstract][Full Text] [Related]
9. A hospital-based case control study of aplastic anemia in Shanghai, China.
Gross SA; Irons RD; Schnatter AR; Ryder J; Wang XQ; Copley GB; Armstrong TW
Chem Biol Interact; 2010 Mar; 184(1-2):165-73. PubMed ID: 20026322
[TBL] [Abstract][Full Text] [Related]
10. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population.
Lv L; Lin G; Gao X; Wu C; Dai J; Yang Y; Zou H; Sun H; Gu M; Chen X; Fu H; Bao L
Am J Hematol; 2011 Feb; 86(2):163-9. PubMed ID: 21264898
[TBL] [Abstract][Full Text] [Related]
12. JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia.
Pich A; Riera L; Sismondi F; Godio L; Davico Bonino L; Marmont F; Francia di Celle P
J Clin Pathol; 2009 Sep; 62(9):798-801. PubMed ID: 19734476
[TBL] [Abstract][Full Text] [Related]
13. Leukemia in relation to occupational exposures to benzene and other agents: a case-control study nested in a cohort of gas and electric utility workers.
Guénel P; Imbernon E; Chevalier A; Crinquand-Calastreng A; Goldberg M
Am J Ind Med; 2002 Aug; 42(2):87-97. PubMed ID: 12125084
[TBL] [Abstract][Full Text] [Related]
14. Shanghai Health Study (2001-2009): What was learned about benzene health effects?
Gross SA; Paustenbach DJ
Crit Rev Toxicol; 2018 Mar; 48(3):217-251. PubMed ID: 29243948
[TBL] [Abstract][Full Text] [Related]
15. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
17. CMML: a biologically distinct myeloproliferative disease.
Cortes J
Curr Hematol Rep; 2003 May; 2(3):202-8. PubMed ID: 12901341
[TBL] [Abstract][Full Text] [Related]
18. Exposure to benzene and non-Hodgkin lymphoma, an epidemiologic overview and an ongoing case-control study in Shanghai.
Wong O; Fu H
Chem Biol Interact; 2005 May; 153-154():33-41. PubMed ID: 15935798
[TBL] [Abstract][Full Text] [Related]
19. Leukemia risk associated with low-level benzene exposure.
Glass DC; Gray CN; Jolley DJ; Gibbons C; Sim MR; Fritschi L; Adams GG; Bisby JA; Manuell R
Epidemiology; 2003 Sep; 14(5):569-77. PubMed ID: 14501272
[TBL] [Abstract][Full Text] [Related]
20. Retrospective occupational exposure assessment for case-control and case-series epidemiology studies based in Shanghai China.
Armstrong TW; Liang Y; Hetherington Y; Bowes SM; Wong O; Fu H; Chen M; Schnatter AR
J Occup Environ Hyg; 2011 Sep; 8(9):561-72. PubMed ID: 21830875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
